From: A case–control study of prevalence of anemia among patients with type 2 diabetes
Parameters | Cases | Controls | p value | |
---|---|---|---|---|
FBG (3.8–6.1 mmol/L) | 7.99±1.30 | 4.66±0.54 | 0.000* | |
Erythropoietin (4.1–19.5 mIU/mL) | 6.35±1.28 | 12.82±1.99 | 0.000* | |
eGFR | Female (80–110 ml/minute/1.73 m2) | 85.41±1.49 | 87.53±1.14 | 0.000* |
Male (90–120 ml/minute/1.73 m2) | 90.16±1.83 | 94.25±1.78 | 0.000* | |
Urea (7–18 mg/dL) | 5.19±1.99 | 3.56±2.11 | 0.000* | |
Na (135–145 mmol/L) | 140.90±6.98 | 135.51±6.84 | 0.000* | |
K (3.5–5.0 mmol/L) | 4.86±0.53 | 4.40±0.58 | 0.000* | |
Cl (95–105 mmol/L) | 105.30±3.95 | 103.40±3.65 | 0.000* | |
Ca (2.1–2.8 mmol/L) | 1.47±0.31 | 1.28±0.26 | 0.001* | |
Creatinine (0.6–1.5 mg/dL) | 2.35±1.74 | 2.37±1.35 | 0.945 | |
HbA1c (4–7 %, 7–8 %, ≥8.5 %) | 7.80±1.04 | 4.61±1.94 | 0.001* |